Physician profile
Ylli Zhubi
NPI 1992124457
$15,327.64
in general payments reported to CMS, 2019-2025
9 companies · $1,340 in 2025
The $1,340 reported for 2025 was more than what 76% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,039 · 2022: $7,321 · 2023: $237 · 2024: $391 · 2025: $1,340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,515 · Travel and Lodging: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,515.21 |
| Travel and Lodging | $453.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,853.50 | 2021-2025 | |
| Davol INC. | $588.42 | 2022-2025 | Phasix Mesh, Channel Drain |
| Ethicon US, LLC | $255.09 | 2021-2024 | Enseal, Harmonic, Echelon Flex |
| Celltrion USA INC. | $139.52 | 2025 | Vegzelma |
| Phathom Pharmaceuticals, INC. | $132.80 | 2024 | Voquezna |
| Merit Medical Systems INC | $131.64 | 2025 | Esophyx |
| Convatec INC. | $114.70 | 2024 | |
| Medtronic, INC. | $70.28 | 2024 | Interstim |
| Axonics, INC. | $41.69 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ylli Zhubi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.